Physician profile
Jason E Barnett
NPI 1295728988
$1,757.71
in general payments reported to CMS, 2019-2025
18 companies · $250 in 2025
The $250 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $560 · 2020: $266 · 2021: $294 · 2022: $68.17 · 2023: $210 · 2024: $110 · 2025: $250.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $532 · Education: $38.54.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $531.71 |
| Education | $38.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $531.74 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Abbvie INC. | $317.93 | 2021-2022 | |
| Glaxosmithkline, LLC. | $251.59 | 2019-2020 | |
| Novo Nordisk INC | $153.14 | 2019-2025 | Ozempic |
| Lilly USA, LLC | $87.23 | 2019-2022 | |
| Amarin Pharma, INC. | $82.13 | 2019-2020 | |
| Allergan, INC. | $52.56 | 2019 | |
| Janssen Pharmaceuticals, INC | $48.31 | 2019 | |
| Pfizer INC. | $43.20 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $41.34 | 2019 | |
| Lundbeck LLC | $38.54 | 2025 | Rexulti |
| Amneal Pharmaceuticals LLC | $25.96 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $16.73 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $16.52 | 2020 | |
| Amgen INC. | $13.90 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $13.38 | 2019 | |
| Shire North American Group INC | $12.08 | 2019 | |
| Novartis Pharmaceuticals Corporation | $11.43 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Barnett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.